New Study: Pharmaceutical Government Affairs & Public Policy Groups Role in Supporting the Patient Journey
CHAPEL HILL, N.C., June 5, 2015 /PRNewswire/ -- Patients are increasingly becoming better informed and getting more involved in the process of selecting and switching therapies. This shift is reshaping the healthcare marketplace and is pushing marketers' efforts more towards patient-focused marketing.
Patient engagement is a critical success factor in the pharmaceutical business world today, and Government Affairs and Public Policy are among the many functions conducting activities to positively impact the "patient journey." According to recent research by benchmarking firm, Best Practices, LLC, these Government Affairs and Public Policy groups focus their patient support programs almost entirely around products that treat chronic care conditions.
The related report, "Patient-Focused Support: How Government Affairs & Public Policy Groups Support the Patient Journey," examines key support tactics and activities by which leading Government Affairs and Public Policy groups support patients.
Key study topics include:
Patient-Focused Support: Activities & Timing
· Number of Products Supported
· Timing by Phase
Patient-Focused Support: Funding
· Investment by Function
· Investment Trends
· Investment Levels
This benchmarking research drew participation from 16 Public Policy and Government Affairs leaders at 16 life sciences companies through a benchmarking survey instrument. In addition, research analysts conducted deep-dive interviews to collect qualitative data and insights.
To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1356.htm
For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at http://www.best-in-class.com/
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.